15 hours ago
Infection Control Market to Reach USD 139.94 Billion by 2030, Driven by Hospital-Acquired Infection Prevention and Sterilization Demand
"Infection Control Market"
Mordor Intelligence has published a new report on the Infection Control Market offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction
According to a 2025 report on infection control market by Mordor Intelligence, the market is estimated at USD 102.36 billion in 2025 and is projected to reach USD 139.94 billion by 2030, growing at a CAGR of 6.45% during the forecast period
The infection control market plays a crucial role in maintaining hygiene and safety standards across hospitals, laboratories, pharmaceutical production units, and life sciences facilities. Infection prevention solutions such as sterilization, disinfection, and cleaning consumables are critical to minimize risks to patients, healthcare staff, and consumers. The market growth is attributed to rising hospital-acquired infection cases, stringent guidelines to control contamination, and high demand for effective sterilization products in medical device reprocessing.
Key Trends
Hospital-acquired infections driving product demand
The report highlights that the increasing number of hospital-acquired infections (HAIs) has made infection control a critical operational area in hospitals and clinics. These infections prolong hospital stays and increase treatment costs, making preventive sterilization, disinfectant usage, and effective waste disposal mandatory to maintain public health standards.
Sterilization segment maintains dominance
Sterilization remains the largest segment in the infection control market, supported by the widespread use of sterilizers in hospitals, outpatient facilities, and diagnostic labs for surgical instrument reprocessing and equipment sterilization. Within sterilization, the use of low-temperature sterilizers is increasing to protect heat-sensitive instruments.
Disinfectants witnessing rising application
Disinfectants are used extensively for surface cleaning, floor cleaning, and equipment cleaning in critical care units and operating theatres. The trend of ready-to-use disinfectant wipes, sprays, and solutions is growing due to convenience and time efficiency in hospitals and diagnostic centres.
Pharmaceutical and life sciences sector driving demand
Beyond hospitals, pharmaceutical manufacturing units, research laboratories, and biotechnology firms require advanced contamination control. The demand for cleanrooms and sterile processing areas contributes significantly to market expansion in the infection control segment.
North America remains the largest market
According to the Mordor Intelligence report, North America continues to hold the largest market share driven by the high number of surgeries performed annually, better healthcare infrastructure, and stringent infection control regulations by organizations such as the CDC and FDA.
Market Segmentation
The infection control market report segments the industry into Product, Service Delivery Mode, End User and Geography.
By Product
Sterilization Products and Services: Includes equipment such as autoclaves and low-temperature sterilizers, along with contract sterilization services. These solutions ensure medical devices and surgical instruments are free from viable microorganisms before reuse.
Cleaning and Disinfection Products: Encompasses disinfectant liquids, sprays, wipes, and detergents used for cleaning surfaces, instruments, and hospital environments to reduce contamination risks.
Protective Barriers: Includes gloves, gowns, face masks, and drapes used by healthcare professionals to prevent cross-contamination during surgical or diagnostic procedures.
By Service Delivery Mode
In-house Infection Control: Refers to infection prevention and control activities managed within healthcare facilities, pharmaceutical manufacturing units, and laboratories using their own sterilization equipment, disinfectants, and staff. Hospitals and large medical centres often maintain in-house sterilization departments to handle equipment reprocessing and facility hygiene efficiently without outsourcing.
Contract Infection Control: Outsourcing sterilization and contamination control services to third-party providers. This is widely used by medical device manufacturers and pharmaceutical companies that require large-scale sterilization but prefer specialized contract service providers to ensure regulatory compliance, cost efficiency, and access to advanced sterilization technologies without heavy capital investments.
Hospitals and Clinics: The largest segment, driven by the constant need for sterilization and disinfection in surgical theatres, ICUs, OPDs, and diagnostic labs to prevent healthcare-associated infections.
Medical Device Companies: Use sterilization services and equipment for manufacturing sterile medical products and packaging to comply with international quality and safety standards.
Pharmaceutical and Life Sciences Companies: Require stringent contamination control and sterilization solutions in production lines, cleanrooms, and research facilities to ensure product safety and regulatory compliance.
Pharmaceutical and Biologics Manufacturers: These include companies involved in producing pharmaceutical drugs, vaccines, and biologic products. They require stringent sterilization, contamination control, and cleanroom hygiene practices throughout manufacturing to ensure product safety, efficacy, and compliance with global regulatory standards.
Life-Science and Food-Processing Facilities: Facilities engaged in life sciences research, diagnostics, and food processing depend on infection control measures to maintain sterile environments, prevent cross-contamination, and uphold product quality and safety during processing, packaging, and storage operations.
Ambulatory Surgery Centers: These are outpatient surgical facilities that perform procedures not requiring hospital admission. Infection control practices such as equipment sterilization, use of disinfectants, and protective barriers are critical to ensure patient safety and prevent surgical site infections in these high-throughput environments.
By Geography
North America: Largest market with well-established infection control guidelines.
Europe: Growing due to increased healthcare spending and focus on patient safety.
Asia-Pacific: Expected to witness the fastest growth owing to rising surgical procedures, healthcare infrastructure development, and increasing awareness.
Middle East & Africa: Growth driven by improving healthcare systems and infection prevention investments.
South America: Developing market with gradual adoption of stringent infection control standards.
Key Players
The infection control market report identifies key companies providing sterilization, disinfection, and protective barrier solutions.
Fortive (Advanced Sterilization Products): Advanced Sterilization Products (ASP) is a part of Fortive Corporation. ASP is known for providing infection prevention solutions, particularly focusing on sterilization and disinfection products used in hospitals and healthcare facilities.
3M Company: Offers a wide range of infection prevention products including sterilization assurance, hand hygiene, and barrier solutions catering to hospitals globally.
Steris Corporation: Known for its sterilization equipment, instrument reprocessing products, and infection prevention consumables for healthcare and life sciences sectors.
Getinge AB: Provides sterilizers, washer-disinfectors, and associated consumables with a strong market presence in hospital sterile processing departments.
Cantel Medical Corp: Specializes in endoscope reprocessing systems, high-level disinfectants, and infection control consumables supporting GI and surgical care.
These companies focus on expanding their infection prevention product portfolios through strategic acquisitions, product launches, and partnerships with hospitals, labs, and pharmaceutical companies to address growing infection control needs.
Conclusion
The infection control market is set for robust growth, with a projected value of USD 139.94 billion by 2030. Rising cases of hospital-acquired infections, expanding surgical procedures, and increasing contamination control requirements in pharmaceuticals and life sciences will continue to support market expansion. While North America remains dominant, Asia-Pacific is expected to witness the fastest growth in the coming years due to healthcare infrastructure development and heightened awareness regarding infection control practices. Companies investing in product innovation and strategic collaborations are well-positioned to meet evolving hospital, laboratory, and industrial hygiene demands.
Industry Related Reports
Dental Infection Control Market: The dental infection control market is segmented by Product Type (Equipment and Consumables), End User (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report provides the value (in USD million) for these segments.
Surgical Site Infection Control Market : Surgical Site Infection Control Market: is segmented by Product (Manual Preprocessors Solution, Disinfectants, and more), Surgery/Procedure (Cataract Surgery, Cesarean Section, and more), Type of Infection (Superficial Incisional SSI, and more), End User (Hospitals, and more), and Geography (North America, Europe, and more). The report provides the value (in USD million) for these segments.
Get More Insights:
Infection surveillance solutions market : Infection Surveillance Solutions Market is segmented by Type (Surgical-Site Infections, Blood-Stream Infections, Catheter-Associated UTIs, and Ventilator-Associated Pneumonia), Offering (Software and Services), Deployment Model (On-Premises and Cloud), End User (Hospitals, Long-Term Care Facilities, Ambulatory Surgery Centers, and more), and Geography. The report provides the market forecasts in terms of value (USD).
About Mordor Intelligence: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact: media@
